Veronica Sanchez Bulis is VP, Corporate Controller of Lyell Immunopharma, Inc.. Currently has a direct ownership of 7,141 shares of LYEL, which is worth approximately $120,897. The most recent transaction as insider was on Dec 30, 2025, when has been sold 936 shares (Common Stock) at a price of $32.32 per share, resulting in proceeds of $30,251. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.14K
n/a 3M change
n/a 12M change
Total Value Held $120,897

Veronica Sanchez Bulis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 30 2025
SELL
Open market or private sale
$30,251 $32.32 p/Share
936 Reduced 11.59%
7,141 Common Stock
Dec 24 2025
SELL
Open market or private sale
$43,929 $38.67 p/Share
1,136 Reduced 12.33%
8,077 Common Stock
Nov 10 2025
SELL
Open market or private sale
$3,847 $16.1 p/Share
239 Reduced 2.53%
9,213 Common Stock
VSB

Veronica Sanchez Bulis

VP, Corporate Controller
South San Francisco, CA

Track Institutional and Insider Activities on LYEL

Follow Lyell Immunopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LYEL shares.

Notify only if

Insider Trading

Get notified when an Lyell Immunopharma, Inc. insider buys or sells LYEL shares.

Notify only if

News

Receive news related to Lyell Immunopharma, Inc.

Track Activities on LYEL